Register now for the Heart Failure Policy Summit 2022

News & Events

26 August 2022
AUTHOR: HFPN Admin

 

We are delighted to announce the Heart Failure Policy Summit 2022!

Taking the form of four virtual sessions held in October and November, this year’s Summit will address how we can engage with policymakers and leaders to improve care for the millions of people living with heart failure across Europe.

Register now
 
 
With new clinical guidelines, evidence and innovation offering the hope of improving the lives of people with heart failure, now is the time to demand access to the best possible care for everyone living with the condition.

The 2022 Summit provides the opportunity for heart failure advocates to come together to focus on the essential topics that will define the future of heart failure care.

This year’s sessions will focus on the following topics:

 
We can’t wait to welcome you to the Heart Failure Policy Summit this autumn.
 

The HFPN has done a phenomenal job of setting the stage for success. Honestly, this is the benchmark for how a summit should be run.’

Marc Bains, Co-founder of the HeartLife Foundation, on the Heart Failure Policy Summit 2021

 

Register for the Heart Failure Policy Summit 2022

Tagged:

More from News & Events

New briefing provides heart failure advocates with actionabl
New briefing provides heart failure advocates with actionabl...
15 May 2023
The final advocacy briefing in our From guidelines to action series highlights the opportunities for heart failure advocates to improve care in Germany. ...
Read article
Tackling the overlooked epidemic of heart failure in Germany
Tackling the overlooked epidemic of heart failure in Germany...
04 May 2023
Heart failure is prevalent in Germany, but is under-recognised. Key stakeholders came together at the German Heart Failure Roundtable to discuss the need for policy change and comp...
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, CSL Vifor, Boehringer Ingelheim and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .